Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06854471 · ClinicalTrials.gov registry record · NA
Effects of Beverage Volume, Glycerol Concentration, and Sodium Concentration on Fluid Balance in Healthy Euhydrated Men and Women at Rest
A NA study of Fluid Balance, sponsored by PepsiCo Global R&D.
- Recruiting
- Registry status
- NA
- Development phase
- 80
- Enrollment target
- 3
- Study locations
NCT06854471: Recruiting NA study of Fluid Balance, sponsored by PepsiCo Global R&D.
NCT06854471 is a NA study of Fluid Balance that is actively recruiting participants, run by PepsiCo Global R&D. The registered enrollment target is 80 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (94% lower). The trial reports 3 study locations across 2 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06854471, a NA study of Fluid Balance, is actively recruiting participants, sponsored by PepsiCo Global R&D.
- RECRUITING
- Registry status
- NA
- Development phase
- 80 participants
- Enrollment target
- 3
- Study locations
Study Summary
The presence of certain ingredients such as sodium and glycerol can facilitate retention of the fluid consumed via renal water reabsorption. To maintain overall whole-body fluid balance, it is important that ingested fluid is retained in the body instead of losing it through urination. The purpose of this study is to determine the effect of sodium and glycerol concentrations at various fluid intake volumes on fluid balance in healthy, euhydrated men and women.
Primary Outcome
Calculated as change in body mass kg and %
Conditions Studied
Interventions
- OTHER Placebo beverage, kiwi-strawberry flavor
- OTHER Electrolyte solution without glycerol beverage 1
- OTHER Electrolyte solution without glycerol beverage 2
- OTHER Electrolyte solution without glycerol beverage 3
- OTHER Electrolyte solution with glycerol beverage 1
Study Locations (3)
Florida
- IMG Academy/GSSI Bradenton Gatorade Sports Science Institute - Bradenton
- GCP Research - St. Petersburg
New York
- Gatorade Sports Science Institute - Valhalla
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 80 participants |
| Start Date | 2025-04-09 |
| Est. Completion | 2025-12-15 |
| Phase | NA |
What NCT06854471 shows while recruiting
NCT06854471 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 80 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (94% lower).
The record links to 1 condition, with Fluid Balance appearing as the primary indexed condition, and to 5 interventions - of which Placebo beverage, kiwi-strawberry flavor is the first listed.
NCT06854471 reports a single indexed study location in Florida, New York.
Frequently Asked Questions
What is clinical trial NCT06854471 about?
NCT06854471 is a clinical study titled "Effects of Beverage Volume, Glycerol Concentration, and Sodium Concentration on Fluid Balance in Healthy Euhydrated Men and Women at Rest". The presence of certain ingredients such as sodium and glycerol can facilitate retention of the fluid consumed via renal water reabsorption. To maintain overall whole-body fluid balance, it is important that ingested fluid is retained in the body instead of losing it through urination. The purpose ...
What is the current status of trial NCT06854471?
This trial is currently recruiting. It is a NA study. The enrollment target is 80 participants. The study started on 2025-04-09. Estimated completion is 2025-12-15.
What conditions does trial NCT06854471 study?
This clinical trial studies the following conditions: Fluid Balance.
What interventions are being tested in trial NCT06854471?
The interventions under investigation include: Placebo beverage, kiwi-strawberry flavor (OTHER), Electrolyte solution without glycerol beverage 1 (OTHER), Electrolyte solution without glycerol beverage 2 (OTHER), Electrolyte solution without glycerol beverage 3 (OTHER), Electrolyte solution with glycerol beverage 1 (OTHER).
Who is sponsoring clinical trial NCT06854471?
This trial is sponsored by PepsiCo Global R&D, which has 47 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06854471 being conducted?
This trial has 3 study locations across Florida, New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Fluid Balance
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06854471's enrollment target sits among peer trials
80 994th of 2000 higher than 941 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01243931 · 80 participants · NA
Optical Coherence Tomography Guided Transepithelial Phototherapeutic Keratectomy
- NCT01659203 · 80 participants · Phase 1
Proton or Photon RT for Retroperitoneal Sarcomas
- NCT01803451 · 80 participants · Early Phase 1
Glucagon-like Peptide 1, Glucose Metabolism and Gastric Bypass
- NCT01964859 · 80 participants · Phase 2
Feasibility Study for Fibroblast Autologous Skin Grafts
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI